Protocol Page


	Study ID (Protocol Number)
	AI266-913


	STUDY LOCATIONS*
	Arnold Palmer Hospital For Children And Woman Orlando, FL 32806	Children's Diagnostic Treatment Center Fort Lauderdale, FL 33301
	Bronx Municipal Hospital Center Bronx, NY 10461	Children's Hospital Boston, MA 02115
	*Not all study site locations may be listed - please check back soon for updated information. For more information regarding other participating countries, please visit clinicaltrials.gov.

	STUDY NAME
	An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection
	STUDY OVERVIEW
	This study is being conducted to assess the safety and tolerability of an oral liquid solution of Sustiva for antiretroviral therapy-naive or therapy-experienced HIV-1 infected children between the ages 3-16 who are failing or intolerant of current antiretroviral regimen and who are unable to swallow Sustiva capsules.

The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit ClinicalTrials.gov for complete information about this and other clinical studies.